ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance

Experimental Cell Research
Su-Young OhEun-Yi Moon

Abstract

The development of paclitaxel-resistance in tumors is one of the most significant obstacles to successful therapy. Thymosin-beta-4 (TB4) has been known as actin-sequestering protein and functions in tumor metastasis. Here, we overexpressed TB4 in HeLa cells (TB4-HeLa) and examined the effect of TB4 in paclitaxel-induced cell death. TB4-HeLa cells showed a higher growth rate and a lower percentage of basal apoptosis than HeLa cells. TB4-HeLa cells were more resistant to paclitaxel-induced cell death than HeLa cells. TB4 transcript expression with paclitaxel treatment was dose-dependently increased in HeLa cells but that was not in TB4-HeLa cells. Small interfering RNA (siRNA) of TB4 inhibited HeLa cell growth and enhanced paclitaxel-induced cell death. Basal ERK phosphorylation was elevated and basal p38 kinase phosphorylation was reduced in paclitaxel non-treated TB4-HeLa cells. When treated with paclitaxel, cell death and resistance-induction were independent of ERK and p38 kinase activation. Paclitaxel-resistance of TB4-HeLa cells was overcome by the inhibition of basal ERK activity with PD98059 pre-treatment. The inhibition of basal p38 kinase activity with SB203580 pre-treatment attenuated the paclitaxel-induced HeLa cell d...Continue Reading

References

Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T L LowA L Goldstein
May 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·K M MalindaH K Kleinman
Sep 1, 1999·The Journal of Investigative Dermatology·K M MalindaH K Kleinman
Mar 7, 2001·Biochemical Pharmacology·K IguchiR Ishida
Apr 20, 2001·The International Journal of Biochemistry & Cell Biology·T HuffE Hannappel
Feb 22, 2002·The Journal of Biological Chemistry·Maud HertzogMarie-France Carlier
Apr 30, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas HuffEwald Hannappel
Sep 23, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Deborah PhilpHynda K Kleinman
Sep 25, 2003·International Journal of Cancer. Journal International Du Cancer·Stanislav ZelivianskiMing-Fong Lin
Nov 20, 2003·Journal of the National Cancer Institute·Allan L Goldstein
Nov 20, 2003·Journal of the National Cancer Institute·Hee-Jae ChaHynda K Kleinman
Dec 6, 2003·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·John C ClohisyYousef Abu-Amer
Mar 24, 2004·Mechanisms of Ageing and Development·D PhilpH K Kleinman
Mar 24, 2004·Investigative Ophthalmology & Visual Science·Gabriel SosneMichelle Kurpakus-Wheater
Mar 25, 2004·The Journal of Biological Chemistry·Michael DomanskiCarine van Heijenoort
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
Apr 13, 2004·Oncogene·Chris J Norbury, Boris Zhivotovsky
Apr 13, 2004·Oncogene·Maria CastedoGuido Kroemer

❮ Previous
Next ❯

Citations

Feb 24, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ping QiuGabriel Sosne
Feb 4, 2011·Cellular Oncology (Dordrecht)·Qing-feng XiangLi-wu Fu
Sep 8, 2010·Clinical & Experimental Metastasis·Eun-Yi MoonJoo-Hyun Kang
Apr 27, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Xiao-qin ZhaoLi-Wu Fu
Oct 19, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jian-Ye ZhangHu-Biao Chen
Jan 17, 2013·Cancer Investigation·Sirinapa SribenjaChangyi Chen
Mar 5, 2015·International Journal of Molecular Medicine·Hirotaka SomeyaTamotsu Kiyoshima
Jun 6, 2013·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Daniel Morales-CanoJosé C Diez
Jul 27, 2007·Immunology Letters·Aarne FleischerAngelita Rebollo
Aug 14, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bilge CanBedri Kandemir
May 25, 2012·International Journal of Cancer. Journal International Du Cancer·Ke-Jun LiuLi-Wu Fu
Oct 11, 2012·Annals of the New York Academy of Sciences·Czeslaw S CierniewskiRadoslaw Bednarek
Jul 4, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Claudia DesiderioGianpiero Tamburrini
May 15, 2007·Annals of the New York Academy of Sciences·Lars-Inge Larsson, Susanne Holck
May 15, 2007·Annals of the New York Academy of Sciences·Gabriel SosneMichelle Kurpakus-Wheater
Oct 5, 2010·Reproduction, Fertility, and Development·Mohamad SalhabSvetlana Uzbekova
Feb 14, 2012·International Journal of Cancer. Journal International Du Cancer·Yun-Kyoung RyuEun-Yi Moon
Nov 12, 2020·Biology·Jaya Aseervatham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis